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EDITORIAL
Should  human  milk  for  premature  children  be fortiﬁed
after discharge  to  improve  neurodevelopmental
outcomes?,
O  leite  materno  deve  ser  fortiﬁcado  para  crianc¸as prematuras  após  terem
alta  para  melhorar  os  resultados  de  neurodesenvolvimento?
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Preterm  children  are  at  higher  risk  for  neurodevelopmental
problems.1 Exclusive  breastfeeding  for  all  children,  includ-
ing  term  infants,  has  been  recommended  for  the  health
beneﬁts  as  well  as  overall  wellbeing.2 In  addition,  improved
developmental  outcomes  have  been  reported  in  term  chil-
dren  who  are  exclusively  breastfed.3 In  preterm  children,
the  advantages  of  human  milk  have  been  well  estab-
lished  for  protection  against  necrotizing  enterocolitis  and
sepsis,  and  trophic  effects.4 However,  it  has  been  recog-
nized  that,  in  preterm  children,  human  milk  alone  may
not  support  optimal  growth  because  of  insufﬁcient  nutrient
content.5 Preterm  infants  are  born  at  a  period  of  signiﬁ-
cant  organ  development  and  are  at  risk  for  deﬁciency  of
essential  nutrients  and  trophic  factors  that  promote  growth
and  brain  development,  such  as  long-chain  polyunsatu-
rated  fatty  acids  and  possibly  others.6 Without  fortiﬁcation,
preterm  children  may  have  growth  retardation,  which  has
been  associated  with  impaired  neurodevelopment.7 There-
fore,  it  has  been  recommended  that  all  preterm  infants
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ith  birth  weight  <1800  g  should  receive  fortiﬁed  human
ilk,  to  add  supplemental  nutrient  fortiﬁcation,  focusing
n  proteins  and  minerals,  and  vitamins  in  particular  dur-
ng  the  neonatal  intensive  care  unit  stay  to  assure  adequate
rowth.8 This  fortiﬁcation  has  been  provided  with  differ-
nt  commercially  available  components,  and  the  quality
f  available  products  varies.  Some  units  use  a  more  stan-
ardized  approached  while  others  use  a  more  individualized
pproach.9
Improved  neurodevelopmental  outcome  and  the  use  of
uman  milk  in  preterm  children  has  been  reported  in  large,
ostly  observational  retrospective  studies10;  a  more  recent
eview  did  not  conclude  that  there  was  improved  neurode-
elopmental  outcome  with  the  use  of  human  milk  in  preterm
hildren  in  their  meta-analyses.11 However,  in  that  review,
tudies  included  did  not  have  much  information  on  fortiﬁer
se.  A  study12 reported  a  paradox  between  preterm  infants
ed  with  human  milk  that  grew  less  during  hospitalization
ompared  to  formula  fed  infants,  but  had  better  neurode-
elopment  in  the  ﬁrst  few  years  of  life;  however,  the  group
hat  was  breastfed  had  higher  birth  weight,  although  the
uthors  controlled  for  growth  restriction  and  socioeconomic
tatus.
Use  of  fortiﬁed  human  milk  during  the  NICU  stay  has
emonstrated  improvement  in  growth  in  preterm  infants12;
owever,  studies  on  long  term  neurodevelopmental  outcome
re  not  conclusive.  A  review  looked  speciﬁcally  for  effects  of
uman  milk  fortiﬁcation  after  discharge  on  development13
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nd  did  not  ﬁnd  differences  in  neurodevelopmental  out-
ome.
There  are  several  human  milk  fortiﬁers  that  had  been
romoted  for  use  with  human  milk  in  premature  infants5;
n  addition,  some  hospitals  use  powdered  preterm  formula
n  order  to  provide  minerals  and  other  needed  nutrients  for
reterm  children.  The  cost  of  commercially  available  for-
iﬁers  is  high,  in  addition  to  problems  with  adding  possible
ontamination  or  excessive  use  of  fortiﬁers  and  effects  on
ong-term  health.
The  present  article  from  da  Cunha  et  al.14 reports  on
 randomized  clinical  trial  of  a  formula  powder  (NESTLÉ®,
evey,  Switzerland)  human  milk  vs.  human  milk  with  no
upplementation  on  infants  born  weighing  less  than  1500  g
fter  being  discharged  from  the  nursery.  This  study  has  mul-
iple  strengths,  such  as  using  a  valid  randomized  design
nd  blinding  developmental  evaluators  to  the  interven-
ion  group.  However,  there  are  several  variables  that  will
e  difﬁcult  to  control  for.  Preterm  infants  represent  a
eterogeneous  population  who  may  require  carefully  indi-
idualized  nutritional  care.  In  addition,  there  is  large
ariation  between  the  content  of  breast  milk  from  one
other  to  another.  Although  this  was  a  randomized  study,
uman  milk  content  was  not  analyzed;  therefore,  a  great
ariability  across  the  different  mothers  included  in  the  study
s  possible.  If  higher-quality  fortiﬁers  and  maternal  vitamin
nd  mineral  supplementation  were  used,  the  results  may
ave  been  statistically  signiﬁcant  between  groups.
Although  not  described  in  the  study,  we  can  assume  that
nfants  were  fed  directly  at  the  breast,  and  only  supple-
ented  children  received  expressed  breast  milk  by  other
eans.
This  study  addresses  an  important  question  regarding
hether  fortiﬁcation  of  human  milk  should  be  recommended
ost-discharge  for  preterm  infants  for  the  theoretical  advan-
ages  of  higher  protein  and  nutrient  content  to  improve
eurodevelopmental  outcomes.  This  becomes  particularly
mportant  for  infants  born  at  extreme  prematurity  with
onger  hospitalization,  who  may  have  a  signiﬁcant  accumu-
ated  deﬁcit  in  nutrients  prior  to  discharge.  It  is  possible  that
ith  newer  guidelines  of  fortiﬁcation  during  the  NICU  stay,
hildren  may  not  be  as  a  disadvantage  as  we  had  assumed
reviously.  Several  investigations  are  ongoing,  looking  into
he  quality  and  duration  of  human  milk  fortiﬁcation.  In
ddition,  fortiﬁcation  after  discharge  is  not  without  difﬁcul-
ies,  considering  the  high  cost  of  multicomponent  fortiﬁers;
erhaps  limited  availability;  possible  contamination  during
ixing,  in  particular  in  areas  with  limited  resources;  and,
erhaps,  even  the  discouragement  of  breastfeeding  when
nfants  are  at  home.
We  are  left  with  the  question  of  whether  we  need  to
ortify  breast  milk  for  preterm  infants  after  discharge  to
mprove  neurodevelopmental  outcomes;  however,  we  can  be
1Peralta-Carcelen  M,  Cloud  HH.
eassured  from  this  study  that  if  there  is  a  clinical  indication
or  fortiﬁcation,  it  must  not  interfere  with  exclusive  breast-
eeding  --  the  desired  method  of  feeding  preterm  infants  --
iven  all  the  advantages  that  breastfeeding  provides.
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